The oncogenic retrovirus Rous sarcoma virus (RSV) is an excellent system for investigating cell-specific differences that result in permissive and nonpermissive retroviral infections in avian and mammalian cells, respectively. It is also an important system for studying expression of the viral oncogenes. Differences in RSV RNA splicing, stability, and transport in permissive avian fibroblasts and nonpermissive mammalian cells will be studied. A number of in vivo DNA transfection and virus infection assays will be used, to study several cis elements within the RSV genome that may represent binding sites for cellular proteins involved in the transport of unspliced viral RNA from the nucleus to the cytoplasm. In vitro splicing assays will be used to characterize avian fibroblast nuclear factors that interact with a cis site upstream of the src 3' splice site and specifically inhibit splicing at this splice site. Additional nonsense codon mutations will be constructed within the src gene coding region to determine how these mutations act to specifically reduce src mRNA levels. The information obtained in the proposed studies will add to knowledge of the role of RNA processing, stability and transport in the maintenance of acute and latent retroviral infections. Because retroviruses bypass the normal requirements for complete splicing prior to transport, it will also add to the understanding of how cellular RNA,processing and transport are regulated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA028051-20
Application #
2894517
Study Section
Virology Study Section (VR)
Program Officer
Cole, John S
Project Start
1979-09-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2001-03-31
Support Year
20
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Amendt, B A; Hesslein, D; Chang, L J et al. (1994) Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol Cell Biol 14:3960-70
Simpson, S B; Stoltzfus, C M (1994) Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels. Mol Cell Biol 14:1835-44
Knight, J B; Stinski, M F; Stoltzfus, C M (1993) Avian sarcoma virus RNA synthesis, RNA splicing and virus production in human foreskin fibroblasts: effect of co-infection with human cytomegalovirus. J Gen Virol 74 ( Pt 12):2629-36
Yeung, K C; Stoltzfus, C M; Stinski, M F (1993) Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter. Virology 195:786-92
Miller, J T; Stoltzfus, C M (1992) Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA. J Virol 66:4242-51
Berberich, S L; Stoltzfus, C M (1991) Analysis of spliced and unspliced Rous sarcoma virus RNAs early and late after infection of chicken embryo fibroblasts: effect of cell culture conditions. Virology 182:135-44
Halpern, M S; England, J M; Coates, L et al. (1991) Regression of v-src DNA-induced sarcomas is under host genetic control. Virology 180:857-60
Berberich, S L; Stoltzfus, C M (1991) Mutations in the regions of the Rous sarcoma virus 3' splice sites: implications for regulation of alternative splicing. J Virol 65:2640-6
Berberich, S L; Macias, M; Zhang, L et al. (1990) Comparison of Rous sarcoma virus RNA processing in chicken and mouse fibroblasts: evidence for double-spliced RNA in nonpermissive mouse cells. J Virol 64:4313-20
Stoltzfus, C M; Fogarty, S J (1989) Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA. J Virol 63:1669-76

Showing the most recent 10 out of 16 publications